Figure 2.
Plaque development in the aortic arch of ApoE−/− mice. The aortic arch of rivaroxaban treated mice showed less plaque formation than control (−46%). This was associated with a more stable phenotype of the plaque as measured by a thicker fibrotic cap (29.50 μm (26.00–40.50)) compared to control (41.00 μm (33.25–54.75)), reduced macrophages (17.68% (13.25–19.46) vs 9.90% (9.23–11.24), and decreased necrotic core (34.56% (27.85–40.63) vs 22.92% (14.94–28.43). *p < 0.05, **p < 0.01, ***p < 0.001. All data were in median (IQR) n = 10 for each group.